Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 3
1989 3
1995 2
1996 4
1997 3
1998 2
1999 3
2000 1
2001 1
2002 1
2003 1
2005 1
2006 3
2007 4
2008 3
2009 4
2010 15
2011 16
2012 16
2013 23
2014 22
2015 20
2016 16
2017 19
2018 22
2019 19
2020 32
2021 28
2022 13
2023 11
2024 8
2025 26
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Atypical Neurofibromatous Neoplasms of Uncertain Biological Potential in Children with Neurofibromatosis Type 1: Report of Two Patients and Review.
Román-Mendoza NM, Martí-Carrera E, Azorín-Cuadrillero D, Blasco-Santana L, Escribano-Pérez M, Vázquez-Gómez F, Martín-Del-Valle F, Duat-Rodríguez A, Hernández-Martín Á. Román-Mendoza NM, et al. Among authors: hernandez martin a. Int J Surg Pathol. 2026 May 14:10668969261438511. doi: 10.1177/10668969261438511. Online ahead of print. Int J Surg Pathol. 2026. PMID: 42135588
Pediatric and Adolescent Nail Disorders.
Giacaman A, Hernández-Martin Á. Giacaman A, et al. Among authors: hernandez martin a. Actas Dermosifiliogr. 2026 Jun;117(6):104610. doi: 10.1016/j.ad.2026.104610. Epub 2026 Mar 10. Actas Dermosifiliogr. 2026. PMID: 41819278 Free article. Review. English, Spanish.
Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry.
Frade-Sosa B, Gómez-Puerta JA, Altabás-González I, Pego-Reigosa JM, Casafont-Solé I, Salman-Monte TC, Hernández-Martín A, Román-Ivorra JA, Piqueras-García M, Garrote-Corral S, Tomero E, de la Mata-Pinilla E, Calvo-Alén J, Martínez-Barrio J, Vidal-Montal P, Cortés-Hernández J, Ramos-Giráldez C, Novoa FJ, Torrente-Segarra V, Fragio-Gil J, Riancho-Zarrabeitia L, Rúa-Figueroa I; BELIMUMAB Multicenter Spanish Register Group (BEL-Spain). Frade-Sosa B, et al. Among authors: hernandez martin a. Rheumatology (Oxford). 2026 Jun 3;65(6):keag076. doi: 10.1093/rheumatology/keag076. Rheumatology (Oxford). 2026. PMID: 41649458
289 results